Approximately 10% of patients with aggressive PC carry germline pathogenic variants in genes with established roles in cancer predisposition (BRCA2, ATM, CHEK2, NBN, BRCA1, PALB2, BRIP1, BARD1). Here, BRCA1 is linked to pachyonychia congenita.